MedPath

TARO-TEMOZOLOMIDE

TARO-TEMOZOLOMIDE

Approved
DIN Number

02443511

Drug Class

Human

Market Date

Jul 23, 2015

Company
HC

Taro Pharmaceuticals Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02443511
AIG Number0138781003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01AX03 TEMOZOLOMIDE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

TEMOZOLOMIDEActive
Strength: 100 MG
Monograph: TEMOZOLOMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.